...
机译:Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama 3510198, Japan;
Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan;
RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, JapanKanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa 9200942, JapanTottori Univ, Grad Sch Med, Det Genet Med & Regenerat Therapeut, Yonago, Tottori 6838503, JapanNagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, JapanKOWA Co Ltd, Pharmaceut Div, Tokyo New Drug Res Labs, Tokyo 1890022, JapanJikei Univ, Sch Med, Dept Lab Med, Tokyo 1058461, JapanTokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, JapanKyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan;
MYCN; hepatocellular carcinoma; cancer stem cell; transcriptome; acyclic retinoid;